NOVARTIS FARMACEUTICA, S.A. secures contract for Pharmaceutical products - Supply of Ranibizumab (DOE), Octreotide (DOE) suspension and Voretigen neparvovec (DOE)

Posted On: 2026-09-14

Spain, Sept. 14 -- Spain based NOVARTIS FARMACEUTICA, S.A. has secured contract from Organo Administrativo de Recursos Contractuales de la Comunidad Autonoma de Euskadi for Pharmaceutical products - Supply of Ranibizumab (DOE), Octreotide (DOE) suspension and Voretigen neparvovec (DOE) . The value of the contract is worth 5700400 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

NOVARTIS FARMACEUTICA, S.A. secures contract for Pharmaceutical products - Supply of Ranibizumab (DOE), Octreotide (DOE) suspension and Voretigen neparvovec (DOE)